✦ LIBER ✦

Anti vascular endothelial growth factor sequential therapy for neovascular age-related macular degeneration: is this the new deal?

✍ Scribed by Neri, Piergiorgio; Mariotti, Cesare; Arapi, Ilir; Bambini, Elisa; Giovannini, Alfonso

Book ID: 118059879
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 213 KB
Volume: 28
Category: Article
ISSN: 0300-7995
DOI: 10.1185/03007995.2012.662153

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-vascular endothelial growth factor

Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: Promises and pitfalls

✍ Dr.Karl Csaky 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Anti-vascular endothelial growth factor

Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: Phase II study results

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Outcomes of cataract surgery in patients

Outcomes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy

✍ Homayoun Tabandeh; Nauman A. Chaudhry; David S. Boyer; Veronica A. Kon-Jara; Har 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Maximum Tolerated Dose of a Humanized An

Maximum Tolerated Dose of a Humanized Anti–Vascular Endothelial Growth Factor Antibody Fragment for Treating Neovascular Age-Related Macular Degeneration

✍ Philip J. Rosenfeld; Steven D. Schwartz; Mark S. Blumenkranz; Joan W. Miller; Ju 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 225 KB

Aflibercept: a Potent Vascular Endotheli

Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases

✍ Raafay Sophie, Abeer Akhtar, Yasir J. Sepah, Mohamed Ibrahim, Millena Bittencour 📂 Article 📅 2012 🏛 Springer Healthcare Communications 🌐 English ⚖ 854 KB

Ocular Complications After Anti–Vascular

Ocular Complications After Anti–Vascular Endothelial Growth Factor Therapy in Medicare Patients With Age-Related Macular Degeneration

✍ Shelley Day; Kofi Acquah; Prithvi Mruthyunjaya; Daniel S. Grossman; Paul P. Lee; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 210 KB